GTBP
GT Biopharma, Inc.
Key Financials
Net Income
$-28354000
↓ 25.2%
Operating Income
$-12422000
↓ 82.0%
Revenue
$0
NaN%
Total Liabilities
$1.3M
↓ 95.7%
Gross Profit
$0
NaN%
EPS (Diluted)
$-6.68
↑ 24.9%
Total Assets
$8.1M
↑ 87.6%
Shareholders' Equity
$5.8M
↑ 92.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | GTBP |
| Company Name | GT Biopharma, Inc. |
| CIK | 109657 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (800) 304-9888 |